Inhibition of the OAS/RNase L pathway by viruses

Current Opinion in Virology

Volumn 15, Issue , 2015, Pages 19-26

  Drappier, Melissa ^a   Michiels, Thomas ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABCE PROTEIN; OLIGOADENYLATE SYNTHETASE; PHOSPHODIESTERASE; RIBONUCLEASE; RIBONUCLEASE L; RLI PROTEIN; SYNTHETASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; 2',5' OLIGOADENYLATE SYNTHETASE; 2-5A-DEPENDENT RIBONUCLEASE; INS1 PROTEIN, INFLUENZA VIRUS; VIRAL PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INHIBITION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; RNA VIRUS; VIRUS INFECTION;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; BASE SEQUENCE; ENDORIBONUCLEASES; HUMANS; RNA VIRUSES; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS DISEASES;

EID: 84938065587     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.07.002     Document Type: Review

References (42)

1. A. Zhou, J. Paranjape, T.L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares, and et al. Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L EMBO J 16 1997 6355 6363
2. C. Bisbal, and R.H. Silverman Diverse functions of RNase L and implications in pathology Biochimie 89 2007 789 798
3. S.E. Brennan-Laun, H.J. Ezelle, X.L. Li, and B.A. Hassel RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting J Interferon Cytokine Res 34 2014 275 288
4. A.G. Hovanessian, and J. Justesen The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation Biochimie 89 2007 779 788
5. J. Justesen, R. Hartmann, and N.O. Kjeldgaard Gene structure and function of the 2′-5′-oligoadenylate synthetase family Cell Mol Life Sci 57 2000 1593 1612
6. I.M. Kerr, and R.E. Brown pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells Proc Natl Acad Sci U S A 75 1978 256 260
7. I.M. Kerr, R.E. Brown, and A.G. Hovanessian Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA Nature 268 1977 540 542
8. A. Zhou, B.A. Hassel, and R.H. Silverman Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action Cell 72 1993 753 765
9. F. Le Roy, C. Bisbal, M. Silhol, C. Martinand, B. Lebleu, and T. Salehzada The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells J Biol Chem 276 2001 48473 48482
10. Y. Han, J. Donovan, S. Rath, G. Whitney, A. Chitrakar, and A. Korennykh Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response Science 343 2014 1244 1248
11. Y. Han, G. Whitney, J. Donovan, and A. Korennykh Innate immune messenger 2-5A tethers human RNase L into active high-order complexes Cell Rep 2 2012 902 913
12. H. Huang, E. Zeqiraj, B. Dong, B.K. Jha, N.M. Duffy, S. Orlicky, N. Thevakumaran, M. Talukdar, M.C. Pillon, D.F. Ceccarelli, and et al. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity Mol Cell 53 2014 221 234
13. X.L. Li, J.A. Blackford, and B.A. Hassel RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection J Virol 72 1998 2752 2759
14. T.W. Nilsen, and C. Baglioni Mechanism for discrimination between viral and host mRNA in interferon-treated cells Proc Natl Acad Sci U S A 76 1979 2600 2604
15. K. Malathi, B. Dong, M. Gale Jr., and R.H. Silverman Small self-RNA generated by RNase L amplifies antiviral innate immunity Nature 448 2007 816 819
16. M. Flodstrom-Tullberg, M. Hultcrantz, A. Stotland, A. Maday, D. Tsai, C. Fine, B. Williams, R. Silverman, and N. Sarvetnick RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection J Immunol 174 2005 1171 1177
17. M.A. Samuel, K. Whitby, B.C. Keller, A. Marri, W. Barchet, B.R. Williams, R.H. Silverman, M. Gale Jr., and M.S. Diamond PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons J Virol 80 2006 7009 7019
18. S.V. Scherbik, J.M. Paranjape, B.M. Stockman, R.H. Silverman, and M.A. Brinton RNase L plays a role in the antiviral response to West Nile virus J Virol 80 2006 2987 2999
19. J.Y. Min, and R.M. Krug The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway Proc Natl Acad Sci U S A 103 2006 7100 7105
20. H.W. Chang, J.C. Watson, and B.L. Jacobs The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase Proc Natl Acad Sci U S A 89 1992 4825 4829
21. H. Huismans, and W.K. Joklik Reovirus-coded polypeptides in infected cells: isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively Virology 70 1976 411 424
22. H.C. Schroder, D. Ugarkovic, R. Wenger, P. Reuter, T. Okamoto, and W.E. Muller Binding of Tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2′-5′)oligoadenylate synthetase AIDS Res Hum Retroviruses 6 1990 659 672
23. H.M. Burgess, and I. Mohr Cellular 5′-3′ mRNA exonuclease Xrn1 controls double-stranded RNA accumulation and anti-viral responses Cell Host Microbe 17 2015 332 344
24. S.W. Liu, G.C. Katsafanas, R. Liu, L.S. Wyatt, and B. Moss Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses Cell Host Microbe 17 2015 320 331
25. L. Zhao, B.K. Jha, A. Wu, R. Elliott, J. Ziebuhr, A.E. Gorbalenya, R.H. Silverman, and S.R. Weiss Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology Cell Host Microbe 11 2012 607 616
26. K.M. Ogden, L. Hu, B.K. Jha, B. Sankaran, S.R. Weiss, R.H. Silverman, J.T. Patton, and B.V. Prasad Structural basis for 2′-5′-oligoadenylate binding and enzyme activity of a viral RNase L antagonist J Virol 2015
27. R. Zhang, B.K. Jha, K.M. Ogden, B. Dong, L. Zhao, R. Elliott, J.T. Patton, R.H. Silverman, and S.R. Weiss Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity Proc Natl Acad Sci U S A 110 2013 13114 13119
28. P.J. Cayley, J.A. Davies, K.G. McCullagh, and I.M. Kerr Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase Eur J Biochem 143 1984 165 174
29. C.L. Hersh, R.E. Brown, W.K. Roberts, E.A. Swyryd, I.M. Kerr, and G.R. Stark Simian virus 40-infected, interferon-treated cells contain 2′,5′-oligoadenylates which do not activate cleavage of RNA J Biol Chem 259 1984 1731 1737
30. A.P. Rice, S.M. Kerr, W.K. Roberts, R.E. Brown, and I.M. Kerr Novel 2′,5′-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells J Virol 56 1985 1041 1044
31. C. Martinand, T. Salehzada, M. Silhol, B. Lebleu, and C. Bisbal RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells Eur J Biochem 254 1998 248 255
32. C. Bisbal, C. Martinand, M. Silhol, B. Lebleu, and T. Salehzada Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway J Biol Chem 270 1995 13308 13317
33. C. Martinand, C. Montavon, T. Salehzada, M. Silhol, B. Lebleu, and C. Bisbal RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells J Virol 73 1999 290 296
34. O. van Eyll, and T. Michiels Influence of the Theiler's virus L∗protein on macrophage infection, viral persistence, and neurovirulence J Virol 74 2000 9071 9077
35. F. Sorgeloos, B.K. Jha, R.H. Silverman, and T. Michiels Evasion of antiviral innate immunity by Theiler's virus L∗protein through direct inhibition of RNase L PLoS Pathog 9 2013 e1003474
36. J.Q. Han, H.L. Townsend, B.K. Jha, J.M. Paranjape, R.H. Silverman, and D.J. Barton A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L J Virol 81 2007 5561 5572
37. J.Q. Han, and D.J. Barton Activation and evasion of the antiviral 2′-5′-oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA RNA 8 2002 512 525
38. M.S. Ibsen, H.H. Gad, L.L. Andersen, V. Hornung, I. Julkunen, S.N. Sarkar, and R. Hartmann Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling Nucleic Acids Res 43 2015 5236 5248
39. J. Zhu, Y. Zhang, A. Ghosh, R.A. Cuevas, A. Forero, J. Dhar, M.S. Ibsen, J.L. Schmid-Burgk, T. Schmidt, M.K. Ganapathiraju, and et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor Immunity 40 2014 936 948
40. A. Ablasser, M. Goldeck, T. Cavlar, T. Deimling, G. Witte, I. Rohl, K.P. Hopfner, J. Ludwig, and V. Hornung cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING Nature 498 2013 380 384
41. L. Zhao, L.D. Birdwell, A. Wu, R. Elliott, K.M. Rose, J.M. Phillips, Y. Li, J. Grinspan, R.H. Silverman, and S.R. Weiss Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus J Virol 87 2013 8408 8418
42. R.H. Silverman Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response J Virol 81 2007 12720 12729